Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
64.45
-0.11 (-0.16%)
At close: May 28, 2026, 4:00 PM EDT
64.43
-0.01 (-0.02%)
After-hours: May 28, 2026, 4:10 PM EDT
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $431.7 million as of May 28, 2026. Its market cap has increased by 101.12% in one year.
Market Cap
431.70M
Enterprise Value
301.31M
1-Year Change
101.12%
Ranking
Category
Stock Price
$64.45
Market Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has increased from $276.16M to $431.70M, an increase of 56.33%. That is a compound annual growth rate of 7.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 432.41M | -0.91% |
| Dec 31, 2025 | 436.37M | 225.25% |
| Dec 31, 2024 | 134.17M | 2,552.79% |
| Dec 29, 2023 | 5.06M | -83.48% |
| Dec 30, 2022 | 30.62M | -24.23% |
| Dec 31, 2021 | 40.42M | -42.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fulcrum Therapeutics | 451.77M |
| Upstream Bio | 449.51M |
| Autolus Therapeutics | 447.12M |
| Sagimet Biosciences | 445.85M |
| Adlai Nortye | 440.00M |
| Ovid Therapeutics | 439.51M |
| ADC Therapeutics | 436.27M |
| Neurogene | 424.60M |